Technology Commercialization

The University of Utah has licensed the following technology to Eliksa Therapeutics and Elk Bioscience:

• Amniotic Fluid Allograft (Eliksa Therapeutics)
• Amnion Membrane Allograft (Eliksa Therapeutics, AmNova™)
• Human Platelet Lysate Serum, (Elk Bioscience, Cell Xpand™)